A NME1 promoter SNP predicts Ara-C associated neurotoxicity in AML patients
Leukemia & Lymphoma
|August 10, 2011
Abstract
No abstract available in PubMed .
More Related Videos
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.5K
07:26High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment
Published on: July 18, 2017
12.1K
